These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33887340)

  • 1. Combining diastolic dysfunction and natriuretic peptides to risk stratify patients with heart failure with reduced ejection fraction.
    Gori M; Claggett B; Senni M; Shah AM; Goldenberg I; Kutyifa V; Knappe D; Pouleur AC; Solomon SD
    Int J Cardiol; 2021 Jul; 335():59-65. PubMed ID: 33887340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.
    Yu CM; Sanderson JE; Shum IO; Chan S; Yeung LY; Hung YT; Cockram CS; Woo KS
    Eur Heart J; 1996 Nov; 17(11):1694-702. PubMed ID: 8922918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES.
    Persson H; Lonn E; Edner M; Baruch L; Lang CC; Morton JJ; Ostergren J; McKelvie RS;
    J Am Coll Cardiol; 2007 Feb; 49(6):687-94. PubMed ID: 17291934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-specific diastolic dysfunction improves prediction of symptomatic heart failure by Stage B heart failure.
    Coller JM; Gong FF; McGrady M; Jelinek MV; Castro JM; Boffa U; Shiel L; Liew D; Stewart S; Krum H; Reid CM; Prior DL; Campbell DJ
    ESC Heart Fail; 2019 Aug; 6(4):747-757. PubMed ID: 31094087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term Registry.
    Kapłon-Cieślicka A; Laroche C; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Maggioni AP; Hage C; Lara-Padrón A; Fucili A; Drożdż J; Seferovic P; Rosano GMC; Mebazaa A; McDonagh T; Lainscak M; Ruschitzka F; Lund LH;
    ESC Heart Fail; 2020 Oct; 7(5):2098-2112. PubMed ID: 32618139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function.
    Mottram PM; Leano R; Marwick TH
    Am J Cardiol; 2003 Dec; 92(12):1434-8. PubMed ID: 14675580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal changes and prognostic implications of left ventricular diastolic function in first acute myocardial infarction.
    Poulsen SH; Jensen SE; Egstrup K
    Am Heart J; 1999 May; 137(5):910-8. PubMed ID: 10220641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum triiodothyronine with B-type natriuretic peptide and severe left ventricular diastolic dysfunction in heart failure with preserved ejection fraction.
    Selvaraj S; Klein I; Danzi S; Akhter N; Bonow RO; Shah SJ
    Am J Cardiol; 2012 Jul; 110(2):234-9. PubMed ID: 22502900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to beta-blockers and natriuretic peptide level in acute heart failure: analysis of data from the Korean acute heart failure registry.
    Park CS; Park JJ; Mebazaa A; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    Clin Res Cardiol; 2021 Sep; 110(9):1392-1403. PubMed ID: 32588127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
    Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
    J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is mild asymptomatic left ventricular systolic dysfunction always predictive of adverse events in high-risk populations? Insights from the DAVID-Berg study.
    Gori M; Redfield MM; Calabrese A; Canova P; Cioffi G; De Maria R; Grosu A; Fontana A; Iacovoni A; Ferrari P; Parati G; Gavazzi A; Senni M
    Eur J Heart Fail; 2018 Nov; 20(11):1540-1548. PubMed ID: 30225956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings.
    Lubien E; DeMaria A; Krishnaswamy P; Clopton P; Koon J; Kazanegra R; Gardetto N; Wanner E; Maisel AS
    Circulation; 2002 Feb; 105(5):595-601. PubMed ID: 11827925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Implications of Functional Mitral Regurgitation Severity in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF).
    Naser N
    Med Arch; 2022 Feb; 76(1):17-22. PubMed ID: 35422569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
    Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.
    Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM
    Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction.
    Brucks S; Little WC; Chao T; Kitzman DW; Wesley-Farrington D; Gandhi S; Shihabi ZK
    Am J Cardiol; 2005 Mar; 95(5):603-6. PubMed ID: 15721099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of diastolic wall strain in patients with chronic heart failure with reduced ejection fraction.
    Soyama Y; Mano T; Goda A; Sugahara M; Masai K; Masuyama T
    Heart Vessels; 2017 Jan; 32(1):68-75. PubMed ID: 27115147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular filling hemodynamics in patients with pulmonary edema and preserved versus reduced left ventricular ejection fraction: a prospective Doppler echocardiographic study.
    Dabbah S; Reisner SA; Aronson D; Agmon Y
    J Am Soc Echocardiogr; 2006 Jun; 19(6):733-43. PubMed ID: 16762750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.